why choose us

First received: July 03, 2026

Clinical Trial: A Clinical Risk Score to Stratify High-risk PanNETs

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pancreatic Neuroendocrine Tumors

Study Type: OBSERVATIONAL


Official Title: A Clinically Applicable Risk Score for Identifying High-risk Pancreatic Neuroendocrine Tumors: Development, Validation, and Biological Correlates

Brief Summary: Considerable heterogeneity exists in the risk of recurrence after curative resection of pancreatic neuroendocrine tumors (PanNETs). Current clinicopathological parameters (e.g., grade, TNM stage) have limited capacity for individualized risk stratification. There is an urgent need for a clinically accessible and operationally simple predictive tools to identify high-risk PanNETs for optimizing personalized postoperative treatment and follow-up strategies. This study aims to identify risk factors associated with…

Read more